Label: information for the user
Anapen 0.30 mg/0.3 ml injectable solution in pre-filled syringe
Adrenaline (epinephrine)
Read this label carefully before starting to use this medication, as it contains important information for you.
1. What Anapen is and for what it is used
2. What you need to know before starting to use Anapen
3. How to use Anapen
4. Possible adverse effects
5. Storage of Anapen
6. Contents of the package and additional information
after using your Autoinjector.
No use Anapen
No known reason exists for not using Anapen in an allergic emergency situation.
Warnings and precautions
Consult your doctor or pharmacist before starting to use Anapen.
Use of Anapen with other medicines
Inform your doctor or pharmacist if you are using or have recently used or may need to use any other medicine, including:
Use of Anapen with alcohol
Alcohol can negatively affect this medicine by increasing its effects.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, or intend to become pregnant, consult your doctor or pharmacist before using this medicine.
Driving and operating machinery
You must not drive or operate machinery after injecting this medicine, as you may still be experiencing the effects of anaphylactic shock.
Anapen contains sodium metabisulfite (E223)(E223)
This medicine can cause severe allergic reactions and bronchospasm (sudden sensation of choking) because it contains sodium metabisulfite (E223).
You must inform your doctor or pharmacist if you know you are allergic to sodium metabisulfite.
Anapen contains a small amount of sodium chloride (salt)
This medicine contains less than 23 mg (1 mmol) of sodium per dose, so it is considered essentially "sodium-free".
Always carry two autoinjectors with you in case the first administration fails or a dose is not sufficient.
The reaction usually begins minutes after exposure to the allergen, and the person may experience:
If you experience these signs and symptoms, use the Anapen autoinjector immediately. Only inject this medication in the outer part of the thigh, never in the buttocks.
Occasionally, a single dose of adrenaline may not be sufficient to completely reverse the effects of a severe allergic reaction. For this reason, your doctor may prescribe more than one unit of Anapen. If your symptoms do not improve or worsen within 5-15 minutes after the first injection, either you or the person with you should administer a second injection. For this reason, you must always carry more than one unit of Anapen with you.
Use in adults
Use in children and adolescents
Children between 15 kg and 30 kg
The usual dose is 0.15 mg.
Children over 30 kg
The usual dose is 0.30 mg.
Anapen is designed as an emergency treatment. You must always seek medical helpimmediatelyafter using Anapen. Call 112, request an ambulance, and indicate "anaphylaxis",even if it seems that the symptoms have improved. You will need to go to a hospital for observation and subsequent treatment, if necessary. This is because the reaction can recur later.
While waiting for the ambulance, you should lie down with your feet elevated unless this makes it difficult to breathe, in which case you should remain seated. Ask someone to stay with you until the ambulance arrives, in case you feel unwell again.
Unconscious patients should be placed on their side in a recovery position.
Instructions for use
It is recommended that family members, caregivers, or teachers also be trained in the correct use of the Anapen autoinjector.
A. Parts of the Anapen Autoinjector
Before using the Anapen Autoinjector, you need to know all the parts of the Anapen Autoinjector. These are shown in the diagram.
Black needle shield (reversible) | Rotary cover of the solution window | Injection indicator | Gray safety cap |
End of needle of the autoinjector | Solution window | Safety closure | Red injector button |
You must not remove the black needle shield or the gray safety cap until the Anapen Autoinjector is about to be used.
B. Checking the Anapen Autoinjector
Before using your Anapen Autoinjector, you must perform the following checks:
1. Rotate the cover that protects the solution window completely in the direction indicated by the arrows to align the lens with the solution window of the Anapen Autoinjector. | |
2. Look through the lens of thesolution windowand check that the solution is clear and colorless. Dispose of the Anapen Autoinjector if the solution is cloudy, colored, or contains particles. | |
3. Make sure theinjection indicatoris not red. If it is red, it means the Anapen Autoinjector has already been activated and should be discarded. | |
4. Rotate the cover over the solution window completely as indicated by the arrows to ensure the solution window is covered. Place the Anapen Autoinjectorback inthe packaging until you need to use it. |
C. Using the Anapen Autoinjector
If the needle shield has been removed,do not place your finger, thumb, or hand over the open end (needle end) of the Anapen Autoinjector.
You must follow these steps to use the Anapen Autoinjector:
1.Remove the black needle shieldby pulling it strongly in the direction of the arrow. This also removes a gray safety cap from the needle. | |
2.Remove the gray safety cap from the red injector button, pulling it as indicated by the arrow. | |
3. Place the open end (needle end) of Anapen against the outer part of the thigh. If necessary, Anapen can be used through light clothing, such as jeans, cotton, or polyester. | |
4.Press the red injector buttonuntil you hear a click.Hold the Anapen Autoinjector against the thigh for 10 seconds.Remove Anapen slowly from the thigh.Massage the injection area lightly. | |
5.The injection indicator will have turned red. This demonstrates that the injection has been completed. If it is not red, you must repeat the injection with a new Anapen. | |
6. After injection, the needle is exposed. To cover it, turn the black needle shield back and, with the wide end, press the needle into the open end (needle end) of the Anapen Autoinjector (as indicated by the arrow). |
Dispose of your used Anapen in the hospital or pharmacy for proper disposal.
If you use more Anapen than you should
Like all medications, this medication may produce adverse effects, although not everyone will experience them.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicinal Products for Human Use:www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box and the auto-injector. The expiration date is the last day of the month indicated.
Do not store at a temperature above 25°C.
Do not use this medication if you observe that the solution is cloudy, has changed color, or contains particles. See the usage instructions to know how to inspect the medication.
Keep the auto-injector in the outer packaging to protect it from light.
Medications should not be disposed of through drains or in the trash. Dispose of the containers and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.
Appearance of the product and contents of the packaging
Anapen is presented in the form of a preloaded syringe with a solution of adrenaline for injection in an automatic injection system (Autoinjector).
It is available in packaging with 1 or 2 units of autoinjectors with a thermoformed protective tray in the cardboard box.Some packaging sizes may only be marketed.
Exposed needle length: 10 mm ± 1.5 mm.
Holder of the marketing authorization and responsible for manufacturing
Holder of marketing authorization:
Bioprojet Pharma,
9 rue Rameau 75002 Paris, France
Responsible for manufacturing:
Owen Mumford Limited
Primsdown Industrial Estate,
Worcester Road, Chipping Norton,
Oxfordshire OX7 5XP,
UK
LYOFAL - SALON DE PROVENCE, ZA La Gandonne,
452 rue du Rémoulaire, SALON DE PROVENCE,
13300, France
This medicine is authorized in the member states of the European Economic Area with the following names:
Austria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovenia, Spain, Sweden and the Netherlands: Anapen
Belgium, Italy: Chenpen
Last review date of this leaflet:04/2024
Anapen is a registered trademark.
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.